Pre-operative diagnosis of breast cancer in screening: problems and pitfalls

References

• Ernst M F, Voogd A C, Coebergh J W, Roukema J A. Breast carcinoma diagnosis, treatment, and prognosis before and after the introduction of mass mammographic screening. Cancer 2004; 100: 1337–1344
   PubMed Web of Science ®Google Scholar
• Shen Y, Yang Y, Inoue L Y, Munsell M F, Miller A B, Berry D A. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. JNCI 2005; 97: 1195–1203
   PubMedGoogle Scholar
• Fischer U, Baum F, Obenauer S, et al. Comparative study in patients with microcalcifications: full-field digital mammography vs screen-film mammography. Eur Radiol 2002; 12: 2679–2683
   PubMed Web of Science ®Google Scholar
• Carder P J, Liston J C. Will the spectrum of lesions prompting a ‘B3’ breast core biopsy increase the benign biopsy rate?. J Clin Pathol 2003; 56: 133–138
   PubMed Web of Science ®Google Scholar
• Dahlstrom J E, Sutton S, Jain S. Histological precision of stereotactic core biopsy in diagnosis of malignant and premalignant breast lesions. Histopathology 1996; 28: 537–541
   PubMed Web of Science ®Google Scholar
• Hoorntje L E, Peeters P H, Mali W P, Borel Rinkes I H. Vacuum-assisted breast biopsy: a critical review. Eur J Cancer 2003; 39: 1676–1683
   PubMed Web of Science ®Google Scholar
• Kettritz U, Rotter K, Schreer I, et al. Stereotactic vacuum-assisted breast biopsy in 2874 patients: a multicenter study. Cancer 2004; 100: 245–251
   PubMed Web of Science ®Google Scholar
• Pinder S E, Provenzano E, Reis-Filho J S. Lobular in situ neoplasia and columnar cell lesions: diagnosis in breast core biopsies and implications for management. Pathology 2007; 39: 208–216
   PubMed Web of Science ®Google Scholar
• Shah V I, Raju U, Chitale D, Deshpande V, Gregory N, Strand V. False-negative core needle biopsies of the breast: an analysis of clinical, radiologic, and pathologic findings in 27 concecutive cases of missed breast cancer. Cancer 2003; 97: 1824–1831
   PubMed Web of Science ®Google Scholar
• Liberman L, Dershaw D D, Glassman J R, et al. Analysis of cancers not diagnosed at stereotactic core breast biopsy. Radiology 1997; 203: 151–157
   PubMed Web of Science ®Google Scholar
• Renshaw A A. Adequate histologic sampling of breast core needle biopsies. Arch Path Lab Med 2001; 125: 1055–1057
   PubMed Web of Science ®Google Scholar
• Margolin F R, Kaufman L, Jacobs R P, Denny S R, Schrumpf J D. Stereotactic core breast biopsy of malignant calcifications: diagnostic yield of cores with and cores without calcifications on specimen radiographs. Radiology 2004; 233: 251–254
   PubMed Web of Science ®Google Scholar
• Schnitt S J, Vincent-Salomon A. Columnar cell lesions of the breast. Adv Anat Pathol 2003; 10: 113–124
   PubMed Web of Science ®Google Scholar
• Schnitt S J. The diagnosis and management of pre-invasive breast disease: flat epithelial atypia—classification, pathologic features and clinical significance. Breast Cancer Res 2003; 5: 263–268
   PubMed Web of Science ®Google Scholar
• Feeley L, Quinn C M. Columnar cell lesions of the breast. Histopathology 2008; 52: 11–19
   PubMed Web of Science ®Google Scholar
• Simpson P T, Gale T, Reis-Filho J S, et al. Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 2005; 29: 734–746
   PubMed Web of Science ®Google Scholar
• Page D L, Dupont W D, Rogers L W, Rados M S. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985; 55: 2698–2708
   PubMed Web of Science ®Google Scholar
• Pinder S E, Ellis I O. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)—current definitions and classification. Breast Cancer Res 2003; 5: 254–257
   PubMed Web of Science ®Google Scholar
• Putti T C, Pinder S E, Elston C W, Lee A H, Ellis I O. Breast pathology practice: most common problems in a consultation service. Histopathology 2005; 47: 445–457
   PubMed Web of Science ®Google Scholar
• Dillon M F, McDermott E W, Hill A D, O'Doherty A, O'Higgins N, Quinn C M. Predictive value of breast lesions of “uncertain malignant potential” and “suspicious for malignancy” determined by needle core biopsy. Ann Surg Oncol 2007; 14: 704–711
   PubMed Web of Science ®Google Scholar
• Lee A H, Denley H E, Pinder S E, et al. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3). Histopathology 2003; 42: 331–336
   PubMed Web of Science ®Google Scholar
• Jacobs T W, Connolly J L, Schnitt S J. Nonmalignant lesions in breast core needle biopsies: to excise or not to excise?. Am J Surg Pathol 2002; 26: 1095–1110
   PubMed Web of Science ®Google Scholar
• Brem R F, Behrndt V S, Sanow L, Gatewood O M. Atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy. AJR 1999; 172: 1405–1407
   PubMed Web of Science ®Google Scholar
• Burbank F. Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: improved accuracy with directional, vacuum-assisted biopsy. Radiology 1997; 202: 843–847
   PubMed Web of Science ®Google Scholar
• Houssami N, Ciatto S, Bilous M, Vezzosi V, Bianchi S. Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3). Br J Cancer 2007; 96: 1253–1257
   PubMed Web of Science ®Google Scholar
• Houssami N, Ciatto S, Ellis I, Ambrogetti D. Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer 2007; 109: 487–495
   PubMed Web of Science ®Google Scholar
• Jackman R J, Burbank F, Parker S H, et al. Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge, directional, vacuum-assisted biopsy. Radiology 1997; 204: 485–488
   PubMed Web of Science ®Google Scholar
• Jackman R J, Nowels K W, Shepard M J, Finkelstein S I, Marzoni F A, Jr. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology 1994; 193: 91–95
   PubMed Web of Science ®Google Scholar
• Ely K A, Carter B A, Jensen R A, Simpson J F, Page D L. Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting. Am J Surg Pathol 2001; 25: 1017–1021
   PubMed Web of Science ®Google Scholar
• Bagnall M J, Evans A J, Wilson A R, et al. Predicting invasion in mammographically detected microcalcification. Clin Radiol 2001; 56: 828–832
   PubMed Web of Science ®Google Scholar
• Renshaw A A. Predicting invasion in the excision specimen from breast core needle biopsy specimens with only ductal carcinoma in situ. Arch Pathol Lab Med 2002; 126: 39–41
   PubMed Web of Science ®Google Scholar
• Rutstein L A, Johnson R R, Poller W R, et al. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ. Breast J 2007; 13: 251–257
   PubMed Web of Science ®Google Scholar
• Jackman R J, Burbank F, Parker S H, et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 2001; 218: 497–502
   PubMed Web of Science ®Google Scholar
• Won B, Reynolds H E, Lazaridis C L, Jackson V P. Stereotactic biopsy of ductal carcinoma in situ of the breast using an 11-gauge vacuum-assisted device: persistent underestimation of disease. AJR 1999; 173: 227–229
   PubMed Web of Science ®Google Scholar
• Yen T W, Hunt K K, Ross M I, et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 2005; 200: 516–526
   PubMed Web of Science ®Google Scholar
• Kennedy M, Masterson A V, Kerin M, Flanagan F. Pathology and clinical relevance of radial scars: a review. J Clin Pathol 2003; 56: 721–724
   PubMed Web of Science ®Google Scholar
• Cawson J N, Malara F, Kavanagh A, Hill P, Balasubramanium G, Henderson M. Fourteen-gauge needle core biopsy of mammographically evident radial scars: is excision necessary?. Cancer 2003; 97: 345–351
   PubMed Web of Science ®Google Scholar
• Douglas-Jones A G, Denson J L, Cox A C, Harries I B, Stevens G. Radial scar lesions of the breast diagnosed by needle core biopsy: analysis of cases containing occult malignancy. J Clin Pathol 2007; 60: 295–298
   PubMed Web of Science ®Google Scholar
• Berg J C, Visscher D W, Vierkant R A, et al. Breast cancer risk in women with radial scars in benign breast biopsies. Breast Cancer Res Treat 2008; 108: 167–174
   PubMed Web of Science ®Google Scholar
• Doyle E M, Banville N, Quinn C M, et al. Radial scars/complex sclerosing lesions and malignancy in a screening programme: incidence and histological features revisited. Histopathology 2007; 50: 607–614
   PubMed Web of Science ®Google Scholar
• Brenner R J, Jackman R J, Parker S H, et al. Percutaneous core needle biopsy of radial scars of the breast: when is excision necessary?. AJR 2002; 179: 1179–1184
   PubMed Web of Science ®Google Scholar
• Douglas-Jones A G, Pace D P. Pathology of R4 spiculated lesions in the breast screening programme. Histopathology 1997; 30: 214–220
   PubMed Web of Science ®Google Scholar
• Farshid G, Rush G. Assessment of 142 stellate lesions with imaging features suggestive of radial scar discovered during population-based screening for breast cancer. Am J Surg Pathol 2004; 28: 1626–1631
   PubMed Web of Science ®Google Scholar
• Sloane J P, Mayers M M. Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology 1993; 23: 225–231
   PubMed Web of Science ®Google Scholar
• Gobbi H, Jensen R A, Simpson J F, Olson S J, Page D L. Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion. Hum Pathol 2001; 32: 785–790
   PubMed Web of Science ®Google Scholar
• Collins L C, Schnitt S J. Papillary lesions of the breast: selected diagnostic and management issues. Histopathology 2008; 52: 20–29
   PubMed Web of Science ®Google Scholar
• Boecker W, Buerger H, Schmitz K, et al. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol 2001; 195: 415–421
   PubMed Web of Science ®Google Scholar
• Otterbach F, Bankfalvi A, Bergner S, Decker T, Krech R, Boecker W. Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathol 2000; 37: 232–240
   PubMed Web of Science ®Google Scholar
• Hoda S A, Rosen P P. Practical considerations in the pathologic diagnosis of needle core biopsies of breast. Am J Clin Pathol 2002; 118: 101–108
   PubMed Web of Science ®Google Scholar
• Ivan D, Selinko V, Sahin A A, Sneige N, Middleton L P. Accuracy of core needle biopsy diagnosis in assessing papillary breast lesions: histologic predictors of malignancy. Mod Pathol 2004; 17: 165–171
   PubMed Web of Science ®Google Scholar
• Agoff S N, Lawton T J. Papillary lesions of the breast with and without atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy?. Am J Clin Pathol 2004; 122: 440–443
   PubMed Web of Science ®Google Scholar
• Ashkenazi I, Ferrer K, Sekosan M, et al. Papillary lesions of the breast discovered on percutaneous large core and vacuum-assisted biopsies: reliability of clinical and pathological parameters in identifying benign lesions. Am J Surg 2007; 194: 183–188
   PubMed Web of Science ®Google Scholar
• Rizzo M, Lund M J, Oprea G, Schniederjan M, Wood W C, Mosunjac M. Surgical follow-up and clinical presentation of 142 breast papillary lesions diagnosed by ultrasound-guided core-needle biopsy. Ann Surg Oncol 2008; 15: 1040–1047
   PubMed Web of Science ®Google Scholar
• Douglas-Jones A G, Verghese A. Diagnostic difficulty arising from displaced epithelium after core biopsy in intracystic papillary lesions of the breast. J Clin Pathol 2002; 55: 780–783
   PubMed Web of Science ®Google Scholar
• Hanby A M, Hughes T A. In situ and invasive lobular neoplasia of the breast. Histopathology 2008; 52: 58–66
   PubMed Web of Science ®Google Scholar
• Foster M C, Helvie M A, Gregory N E, Rebner M, Nees A V, Paramagul C. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?. Radiology 2004; 231: 813–819
   PubMed Web of Science ®Google Scholar
• Cohen M A. Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reasons why. Radiology 2004; 231: 617–621
   PubMed Web of Science ®Google Scholar
• Elsheikh T M, Silverman J F. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol 2005; 29: 534–543
   PubMed Web of Science ®Google Scholar
• Menon S, Porter G J, Evans A J, et al. The significance of lobular neoplasia on needle core biopsy of the breast. Virchows Arch 2008; 452: 473–479
   PubMed Web of Science ®Google Scholar
• Page D L, Schuyler P A, Dupont W D, Jensen R A, Plummer W D, Jr, Simpson J F. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 2003; 361: 125–129
   PubMed Web of Science ®Google Scholar
• Da Silva L, Parry S, Reid L, et al. Aberrant expression of E-cadherin in lobular carcinomas of the breast. Am J Surg Pathol 2008; 32: 773–783
   PubMed Web of Science ®Google Scholar
• Shin S J, Rosen P P. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Path Lab Med 2002; 126: 697–701
   PubMed Web of Science ®Google Scholar
• Fadare O, Dadmanesh F, Alvarado-Cabrero I, et al. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases. Am J Surg Pathol 2006; 30: 1445–1453
   PubMed Web of Science ®Google Scholar
• Brem R F, Lechner M C, Jackman R J, et al. Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. AJR 2008; 190: 637–641
   PubMed Web of Science ®Google Scholar
• Wells C A, El-Ayat G A. Non-operative breast pathology: apocrine lesions. J Clin Pathol 2007; 60: 1313–1320
   PubMed Web of Science ®Google Scholar
• O'Malley F P, Bane A. An update on apocrine lesions of the breast. Histopathology 2008; 52: 3–10
   PubMed Web of Science ®Google Scholar
• Leal C, Henrique R, Monteiro P, et al. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. Hum Pathol 2001; 32: 487–493
   PubMed Web of Science ®Google Scholar
• Hoda S A, Rosen P P. Observations on the pathologic diagnosis of selected unusual lesions in needle core biopsies of breast. Breast J 2004; 10: 522–527
   PubMedGoogle Scholar
• Renshaw A A. Can mucinous lesions of the breast be reliably diagnosed by core needle biopsy?. Am J Clin Pathol 2002; 118: 82–84
   PubMed Web of Science ®Google Scholar
• Renshaw A A. Minimal (<or = 0.1 cm) invasive carcinoma in breast core needle biopsies. Incidence, sampling, associated findings, and follow-up. Arch Pathol Lab Med 2004; 128: 996–999
   PubMed Web of Science ®Google Scholar
• Adem C, Reynolds C, Adlakha H, Roche P C, Nascimento A G. Wide spectrum screening keratin as a marker of metaplastic spindle cell carcinoma of the breast: an immunohistochemical study of 24 patients. Histopathology 2002; 40: 556–562
   PubMed Web of Science ®Google Scholar
• Al-Nafussi A. Spindle cell tumours of the breast: practical approach to diagnosis. Histopathology 1999; 35: 1–13
   PubMed Web of Science ®Google Scholar
• Lee A H. Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breast. Histopathology 2008; 52: 45–57
   PubMed Web of Science ®Google Scholar
• Sneige N, Yaziji H, Mandavilli S R, et al. Low-grade (fibromatosis-like) spindle cell carcinoma of the breast. Am J Surg Pathol 2001; 25: 1009–1016
   PubMed Web of Science ®Google Scholar
• Khan H N, Wyld L, Dunne B, et al. Spindle cell carcinoma of the breast: a case series of a rare histological subtype. Eur J Surg Oncol 2003; 29: 600–603
   PubMed Web of Science ®Google Scholar
• Ho B C, Tan H W, Lee V K, Tan P H. Preoperative and intraoperative diagnosis of low-grade adenosquamous carcinoma of the breast: potential diagnostic pitfalls. Histopathology 2006; 49: 603–611
   PubMed Web of Science ®Google Scholar
• Denley H, Pinder S E, Tan P H, et al. Metaplastic carcinoma of the breast arising within complex sclerosing lesion: a report of five cases. Histopathology 2000; 36: 203–209
   PubMed Web of Science ®Google Scholar
• Gobbi H, Simpson J F, Jensen R A, Olson S J, Page D L. Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas. Mod Pathol 2003; 16: 893–901
   PubMed Web of Science ®Google Scholar
• Reis-Filho J S, Milanezi F, Steele D, et al. Metaplastic breast carcinomas are basal-like tumours. Histopathology 2006; 49: 10–21
   PubMed Web of Science ®Google Scholar
• Lee A H. The histological diagnosis of metastases to the breast from extramammary malignancies. J Clin Pathol 2007; 60: 1333–1341
   PubMed Web of Science ®Google Scholar
• Tot T. Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer 2002; 38: 758–763
   PubMed Web of Science ®Google Scholar
• Chu P G, Weiss L M. Keratin expression in human tissues and neoplasms. Histopathology 2002; 40: 403–439
   PubMed Web of Science ®Google Scholar
• Harvey J M, Clark G M, Osborne C K, Allred D C. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999; 17: 1474–1481
   PubMed Web of Science ®Google Scholar